Losing the glutamate at position 3 sharply reduces its binding to IGF-binding proteins, which is why in cell culture it is reported to be roughly ten times more potent than intact IGF-1 at driving cell proliferation and hypertrophy [1]
Rao Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran Sina Rashedi Department of Geography, Soran University, Soran, Iraq Azad Rasul Department of Biomedical Engineering, Khulna University of Engineering and Technology, Khulna, Bangladesh Zubair Ahmed Ratan Department of Health Services Management, Shiraz University of Medical Sciences, Shiraz, Iran Ramin Ravangard WHO Collaborating Centre for Public Health Education and Training, Imperial College London, London, UK David Laith Rawaf Inovus Medical, St Helens, UK David Laith Rawaf Department of Computer Science, Boston University, Boston, MA, USA Reza Rawassizadeh Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Iman Razeghian-Jahromi Department Biological Sciences, King Abdulaziz University, Jeddah, Egypt Elrashdy Moustafa Mohamed Redwan Department of Protein Research, Research and Academic Institution, Alexandria, Egypt Elrashdy Moustafa Mohamed Redwan School of Medicine, Western Sydney University, Campbelltown, NSW, Australia Andre M
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-1: potential role in idiopathic pulmonary fibrosis
Zhang W, Yan W, Qian N
